 |
Previous Article | Next Article 
The Journal of Neuroscience, June 15, 2002, 22(12):4842-4849
Calpain Activation in Huntington's Disease
Juliette
Gafni and
Lisa M.
Ellerby
Buck Institute for Age Research, Novato, California 94945
Huntington's disease (HD) is a neurodegenerative disorder caused
by a CAG expansion that results in elongation of the polyglutamine tract at the N terminus of huntingtin (Htt). Abnormal proteolytic processing of mutant Htt has been implicated as a critical step in the
initiation of HD. The protease(s) involved in this process has not been
fully characterized. Here we report that activated calpain was detected
in the caudate of human HD tissue but not in age-matched controls. In
addition, one of the major N-terminal Htt proteolytic fragments found
in human HD tissue appears to be derived from calpain cleavage. Htt
fragments in HD lysates were similar in size to those produced by
exposure of in vitro-translated Htt to exogenous
calpain. Incubation of in vitro-translated Htt with
calpain generated a cascade of cleavage events with an initial intermediate cleavage product at 72 kDa and a final cleavage product at
47 kDa. The rate of cleavage of Htt by calpain was
polyglutamine-length-dependent. These results suggest that cleavage of
Htt in human HD tissue is mediated in part by the
Ca2+-activated neutral protease, calpain.
Key words:
huntingtin; Huntington's disease; calpain; proteases; triplet repeat disease; neurodegeneration
Copyright © 2002 Society for Neuroscience 0270-6474/02/22124842-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
C. T. Aiken, J. S. Steffan, C. M. Guerrero, H. Khashwji, T. Lukacsovich, D. Simmons, J. M. Purcell, K. Menhaji, Y.-Z. Zhu, K. Green, et al.
Phosphorylation of Threonine 3: IMPLICATIONS FOR HUNTINGTIN AGGREGATION AND NEUROTOXICITY
J. Biol. Chem.,
October 23, 2009;
284(43):
29427 - 29436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gafni, X. Cong, S. F. Chen, B. W. Gibson, and L. M. Ellerby
Calpain-1 Cleaves and Activates Caspase-7
J. Biol. Chem.,
September 11, 2009;
284(37):
25441 - 25449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Rudinskiy, Y. Grishchuk, A. Vaslin, J. Puyal, A. Delacourte, H. Hirling, P. G. H. Clarke, and R. Luthi-Carter
Calpain Hydrolysis of {alpha}- and {beta}2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration
J. Biol. Chem.,
May 1, 2009;
284(18):
12447 - 12458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ratovitski, M. Gucek, H. Jiang, E. Chighladze, E. Waldron, J. D'Ambola, Z. Hou, Y. Liang, M. A. Poirier, R. R. Hirschhorn, et al.
Mutant Huntingtin N-terminal Fragments of Specific Size Mediate Aggregation and Toxicity in Neuronal Cells
J. Biol. Chem.,
April 17, 2009;
284(16):
10855 - 10867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pennuto, I. Palazzolo, and A. Poletti
Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity
Hum. Mol. Genet.,
April 15, 2009;
18(R1):
R40 - R47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Ehrnhoefer, S. L. Butland, M. A. Pouladi, and M. R. Hayden
Mouse models of Huntington disease: variations on a theme
Dis. Model. Mech.,
March 1, 2009;
2(3-4):
123 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Cowan, M. M. Y. Fan, J. Fan, J. Shehadeh, L. Y. J. Zhang, R. K. Graham, M. R. Hayden, and L. A. Raymond
Polyglutamine-Modulated Striatal Calpain Activity in YAC Transgenic Huntington Disease Mouse Model: Impact on NMDA Receptor Function and Toxicity
J. Neurosci.,
November 26, 2008;
28(48):
12725 - 12735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-E. Wang, S. Tydlacka, A. L. Orr, S.-H. Yang, R. K. Graham, M. R. Hayden, S. Li, A. W.S. Chan, and X.-J. Li
Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease
Hum. Mol. Genet.,
September 1, 2008;
17(17):
2738 - 2751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Warby, C. N. Doty, R. K. Graham, J. B. Carroll, Y.-Z. Yang, R. R. Singaraja, C. M. Overall, and M. R. Hayden
Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus
Hum. Mol. Genet.,
August 1, 2008;
17(15):
2390 - 2404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Y. Yuen, Y. Ren, and Z. Yan
Postsynaptic Density-95 (PSD-95) and Calcineurin Control the Sensitivity of N-Methyl-D-aspartate Receptors to Calpain Cleavage in Cortical Neurons
Mol. Pharmacol.,
August 1, 2008;
74(2):
360 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Metzger, J. Rong, H.-P. Nguyen, A. Cape, J. Tomiuk, A. S. Soehn, P. Propping, Y. Freudenberg-Hua, J. Freudenberg, L. Tong, et al.
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
Hum. Mol. Genet.,
April 15, 2008;
17(8):
1137 - 1146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, M. C. Liu, and K. K. W. Wang
Calpain in the CNS: From Synaptic Function to Neurotoxicity
Sci. Signal.,
April 8, 2008;
1(14):
re1 - re1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Luo, H. Mizuta, and D. C. Rubinsztein
p21-activated kinase 1 promotes soluble mutant huntingtin self-interaction and enhances toxicity
Hum. Mol. Genet.,
March 15, 2008;
17(6):
895 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Orr, S. Li, C.-E. Wang, H. Li, J. Wang, J. Rong, X. Xu, P. G. Mastroberardino, J. T. Greenamyre, and X.-J. Li
N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
J. Neurosci.,
March 12, 2008;
28(11):
2783 - 2792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Akashiba, Y. Ikegaya, N. Nishiyama, and N. Matsuki
Differential Involvement of Cell Cycle Reactivation between Striatal and Cortical Neurons in Cell Death Induced by 3-Nitropropionic Acid
J. Biol. Chem.,
March 7, 2008;
283(10):
6594 - 6606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schilling, J. Gafni, C. Torcassi, X. Cong, R. H. Row, M. A. LaFevre-Bernt, M. P. Cusack, T. Ratovitski, R. Hirschhorn, C. A. Ross, et al.
Huntingtin Phosphorylation Sites Mapped by Mass Spectrometry: MODULATION OF CLEAVAGE AND TOXICITY
J. Biol. Chem.,
August 18, 2006;
281(33):
23686 - 23697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jacquard, Y. Trioulier, F. Cosker, C. Escartin, N. Bizat, P. Hantraye, J. M. Cancela, G. Bonvento, and E. Brouillet
Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation
FASEB J,
May 1, 2006;
20(7):
1021 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pardo, E. Colin, E. Regulier, P. Aebischer, N. Deglon, S. Humbert, and F. Saudou
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421
J. Neurosci.,
February 1, 2006;
26(5):
1635 - 1645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Rangone, R. Pardo, E. Colin, J.-A. Girault, F. Saudou, and S. Humbert
Phosphorylation of Arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced Toxicity by Rescuing Proteasome Impairment
J. Biol. Chem.,
June 10, 2005;
280(23):
22021 - 22028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Goti, S. M. Katzen, J. Mez, N. Kurtis, J. Kiluk, L. Ben-Haiem, N. A. Jenkins, N. G. Copeland, A. Kakizuka, A. H. Sharp, et al.
A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration
J. Neurosci.,
November 10, 2004;
24(45):
10266 - 10279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gafni, E. Hermel, J. E. Young, C. L. Wellington, M. R. Hayden, and L. M. Ellerby
Inhibition of Calpain Cleavage of Huntingtin Reduces Toxicity: ACCUMULATION OF CALPAIN/CASPASE FRAGMENTS IN THE NUCLEUS
J. Biol. Chem.,
May 7, 2004;
279(19):
20211 - 20220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Wu and P. C. Tai
Cys32 and His105 Are the Critical Residues for the Calcium-dependent Cysteine Proteolytic Activity of CvaB, an ATP-binding Cassette Transporter
J. Biol. Chem.,
January 9, 2004;
279(2):
901 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-H. Qin, Y. Wang, E. Sapp, B. Cuiffo, E. Wanker, M. R. Hayden, K. B. Kegel, N. Aronin, and M. DiFiglia
Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction
J. Neurosci.,
January 7, 2004;
24(1):
269 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-H. Qin, Y. Wang, K. B. Kegel, A. Kazantsev, B. L. Apostol, L. M. Thompson, J. Yoder, N. Aronin, and M. DiFiglia
Autophagy regulates the processing of amino terminal huntingtin fragments
Hum. Mol. Genet.,
December 15, 2003;
12(24):
3231 - 3244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Regulier, Y. Trottier, V. Perrin, P. Aebischer, and N. Deglon
Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum
Hum. Mol. Genet.,
November 1, 2003;
12(21):
2827 - 2836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bizat, J.-M. Hermel, S. Humbert, C. Jacquard, C. Creminon, C. Escartin, F. Saudou, S. Krajewski, P. Hantraye, and E. Brouillet
In Vivo Calpain/Caspase Cross-talk during 3-Nitropropionic Acid-induced Striatal Degeneration: IMPLICATION OF A CALPAIN-MEDIATED CLEAVAGE OF ACTIVE CASPASE-3
J. Biol. Chem.,
October 31, 2003;
278(44):
43245 - 43253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, F. Cao, Z. Wang, Z.-X. Yu, H.-P. Nguyen, J. Evans, S.-H. Li, and X.-J. Li
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity
J. Cell Biol.,
October 13, 2003;
163(1):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Slow, J. van Raamsdonk, D. Rogers, S. H. Coleman, R. K. Graham, Y. Deng, R. Oh, N. Bissada, S. M. Hossain, Y.-Z. Yang, et al.
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
Hum. Mol. Genet.,
July 1, 2003;
12(13):
1555 - 1567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bizat, J.-M. Hermel, F. Boyer, C. Jacquard, C. Creminon, S. Ouary, C. Escartin, P. Hantraye, S. Kajewski, and E. Brouillet
Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration Induced In Vivo by 3-Nitropropionate: Implications for Huntington's Disease
J. Neurosci.,
June 15, 2003;
23(12):
5020 - 5030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Nucifora Jr., L. M. Ellerby, C. L. Wellington, J. D. Wood, W. J. Herring, A. Sawa, M. R. Hayden, V. L. Dawson, T. M. Dawson, and C. A. Ross
Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity
J. Biol. Chem.,
April 4, 2003;
278(15):
13047 - 13055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-X. Yu, S.-H. Li, J. Evans, A. Pillarisetti, H. Li, and X.-J. Li
Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease
J. Neurosci.,
March 15, 2003;
23(6):
2193 - 2202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-L. Wu, T. M. O'Kane, R. W. Scott, M. J. Savage, and D. Bozyczko-Coyne
Protein Tyrosine Phosphatases Are Up-regulated and Participate in Cell Death Induced by Polyglutamine Expansion
J. Biol. Chem.,
November 8, 2002;
277(46):
44208 - 44213.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|